Rossari Biotech Limited (ROSSARI.NS)
INR 803.9
(-1.06%)
INR 803.9
(-1.06%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 299.7 Million | 1.52 Billion | 293.58 Million | 477.67 Million | 548.28 Million | 711.77 Million |
| Net Income | 1.3 Billion | 1.44 Billion | 1.36 Billion | 1.06 Billion | 880.59 Million | 633.92 Million |
| Depreciation & Amortization | 603.9 Million | 629.31 Million | 480.55 Million | 228.29 Million | 168.52 Million | 122.64 Million |
| Deferred income taxes | - | -482.95 Million | -524.01 Million | -335.38 Million | -214.91 Million | - |
| Stock-based compensation | 6.87 Million | 9.43 Million | 18.31 Million | 16.27 Million | 4.63 Million | - |
| Change in working capital | -1.56 Billion | -271.97 Million | -1.12 Billion | -483.05 Million | -310.68 Million | 113.91 Million |
| Other non-cash items | 2.73 Billion | 197.93 Million | 85.89 Million | -12.73 Million | 20.13 Million | -158.7 Million |
| Investing Cash Flow | -1.05 Billion | -1.8 Billion | -2.98 Billion | -371.79 Million | -1.9 Billion | -364.22 Million |
| Investments in PPE | -1.31 Billion | -328.76 Million | -382.25 Million | -580.84 Million | -759.71 Million | -439.91 Million |
| Acquisitions | -122.39 Million | -985.31 Million | -3.55 Billion | -43.39 Million | -43.93 Million | 10 Thousand |
| Investment purchases | -90.23 Million | -534.37 Million | 68.8 Million | -195.31 Million | -181.31 Million | -69.4 Million |
| Sales/Maturities of investments | 466.27 Million | 534.37 Million | 15.54 Million | 195.31 Million | 181.31 Million | 69.39 Million |
| Other Investing Activities | 458.02 Million | -494.87 Million | 859.13 Million | 252.44 Million | -1.09 Billion | 75.69 Million |
| Financing Cash Flow | 321.74 Million | 608.55 Million | 2.91 Billion | -245.92 Million | 1.56 Billion | -291.5 Million |
| Debt repayment | -318.99 Million | -655.01 Million | -48.12 Million | -339.6 Million | -24.16 Million | -521.54 Million |
| Dividends payments | -27.58 Million | -27.53 Million | -27.53 Million | -25.38 Million | -26.48 Million | -105.92 Million |
| Common Stock Repurchased | - | -655.01 Million | -2.96 Billion | -309.47 Million | -975.84 Million | - |
| Common Stock Issuance | 38.45 Million | 42.12 Million | 3.01 Billion | 426.53 Million | 1 Billion | - |
| Other Financing Activities | 313.36 Million | 1.9 Billion | 2.94 Billion | 2 Million | 1.59 Billion | 335.96 Million |
| Accounts receivables | -1.12 Billion | -279.69 Million | -425.28 Million | -404.5 Million | -204.06 Million | -344.23 Million |
| Accounts payables | 496.34 Million | 400 Thousand | -222.78 Million | 241.7 Million | -68.97 Million | 672.19 Million |
| Inventory | -938.48 Million | 7.32 Million | -481.85 Million | -320.25 Million | -37.65 Million | -214.02 Million |
| Other working capital | 496.34 Million | - | - | - | - | -30 Thousand |
| Cash at beginning of period | 698.32 Million | 374.77 Million | 152.08 Million | 292.11 Million | 57.42 Million | 6.25 Million |
| Cash at end of period | 302.11 Million | 698.32 Million | 374.77 Million | 152.08 Million | 292.11 Million | 57.42 Million |
| Capital Expenditure | -1.31 Billion | -328.76 Million | -382.25 Million | -580.84 Million | -759.71 Million | -439.91 Million |
| Effect of forex changes on cash | -2.54 Million | 2.02 Million | - | 10 Thousand | 19.99 Million | -4.88 Million |
| Net cash flow / Change in cash | -396.21 Million | 323.55 Million | 222.69 Million | -140.03 Million | 234.69 Million | 51.17 Million |
| Free Cash Flow | -1.01 Billion | 1.19 Billion | -88.67 Million | -103.17 Million | -211.43 Million | 271.86 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 348.99 Million | 341.32 Million | 1.3 Billion | 343.9 Million | 329.48 Million | 292.19 Million |
| Depreciation & Amortization | - | - | 603.9 Million | 150.88 Million | 151.14 Million | 141.14 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 9.17 Million | 6.87 Million | - | - | - |
| Change in working capital | - | - | -1.56 Billion | - | - | - |
| Other non-cash items | -348.99 Million | -350.49 Million | 2.73 Billion | -343.9 Million | -329.48 Million | -292.19 Million |
| Investing Cash Flow | - | - | -1.05 Billion | - | - | - |
| Investments in PPE | - | - | -1.31 Billion | - | - | - |
| Acquisitions | - | - | -122.39 Million | - | - | - |
| Investment purchases | - | - | -90.23 Million | - | - | - |
| Sales/Maturities of investments | - | - | 466.27 Million | - | - | - |
| Other Investing Activities | - | - | 458.02 Million | - | - | - |
| Financing Cash Flow | - | - | 321.74 Million | - | - | - |
| Debt repayment | - | - | -318.99 Million | - | - | - |
| Dividends payments | - | - | -27.58 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 38.45 Million | - | - | - |
| Other Financing Activities | - | - | 313.36 Million | - | - | - |
| Accounts receivables | - | - | -1.12 Billion | - | - | - |
| Accounts payables | - | - | 496.34 Million | - | - | - |
| Inventory | - | - | -938.48 Million | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | - | 698.32 Million | 506.18 Million | 203.9 Million | 698.32 Million |
| Cash at end of period | - | - | 302.11 Million | 807.94 Million | 506.18 Million | 980.6 Million |
| Capital Expenditure | - | - | -1.31 Billion | - | - | - |
| Effect of forex changes on cash | - | - | -2.54 Million | - | - | - |
| Net cash flow / Change in cash | - | - | -396.21 Million | 301.76 Million | 302.28 Million | 282.28 Million |
| Free Cash Flow | - | - | -1.01 Billion | 301.76 Million | 302.28 Million | 282.28 Million |
6483
1846
HLGN
3319
300775
3710